Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. [electronic resource]
- Journal of the National Cancer Institute Feb 2006
- 181-9 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1460-2105
10.1093/jnci/djj020 doi
Antineoplastic Agents--therapeutic use Apoptosis--drug effects Biomarkers, Tumor--metabolism Blotting, Western Carcinoma, Squamous Cell--drug therapy Cell Line, Tumor Cisplatin--therapeutic use Cyclin-Dependent Kinase Inhibitor p21--metabolism DNA Methylation Down-Regulation Gene Expression Regulation, Neoplastic Head and Neck Neoplasms--drug therapy Humans Luciferases--metabolism Lymphocytes--metabolism Polymerase Chain Reaction Promoter Regions, Genetic Respiratory Mucosa--metabolism STAT1 Transcription Factor--metabolism Transfection Transplantation, Heterologous Up-Regulation